4.6 Review

The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group

Journal

BRITISH JOURNAL OF DERMATOLOGY
Volume 182, Issue 6, Pages 1331-1342

Publisher

OXFORD UNIV PRESS
DOI: 10.1111/bjd.18643

Keywords

-

Categories

Funding

  1. National Institute for Health Research (NIHR) Career Development Fellowship [CDF-2014-07-037]
  2. NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London
  3. AbbVie
  4. Amgen
  5. Asana
  6. Celgene
  7. Chugai
  8. Dermavant
  9. Dermira
  10. Eli Lilly
  11. Galderma
  12. Incyte
  13. LEO Pharma
  14. Kyowa Kirin
  15. Novartis
  16. Pierre Fabre
  17. Pfizer
  18. Sanofi Genzyme
  19. Regeneron Pharmaceuticals
  20. Sienna
  21. Valeant

Ask authors/readers for more resources

Patients with atopic dermatitis (AD) have an increased risk of bacterial skin infections, which cause significant morbidity and, if untreated, may become systemic. Staphylococcus aureus colonizes the skin of most patients with AD and is the most common organism to cause infections. Overt bacterial infection is easily recognized by the appearance of weeping lesions, honey-coloured crusts and pustules. However, the wide variability in clinical presentation of bacterial infection in AD and the inherent features of AD - cutaneous erythema and warmth, oozing associated with oedema, and regional lymphadenopathy - overlap with those of infection, making clinical diagnosis challenging. Furthermore, some features may be masked because of anatomical site- and skin-type-specific features, and the high frequency of S. aureus colonization in AD makes positive skin swab culture of suspected infection unreliable as a diagnostic tool. The host mechanisms and microbial virulence factors that underlie S. aureus colonization and infection in AD are incompletely understood. The aim of this article is to present the latest evidence from animal and human studies, including recent microbiome research, to define the clinical features of bacterial infections in AD, and to summarize our current understanding of the host and bacterial factors that influence microbial colonization and virulence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available